US 11505574
Modulation of P53 for the treatment of cancer
granted A61KA61K31/711A61K38/00
Quick answer
US patent 11505574 (Modulation of P53 for the treatment of cancer) held by The Regents of the University of California expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/711, A61K38/00, A61K45/06, A61K47/42